iBio, Inc.IBIONYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR+37.2%
5Y CAGR-36.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+37.2%/yr
vs -49.0%/yr prior
5Y CAGR
-36.6%/yr
Recent acceleration
Acceleration
+86.2pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.34 | +180.6% |
| 2024 | -9.11 | - |
| 2023 | 0.00 | -100.0% |
| 2022 | 2.84 | -97.3% |
| 2021 | 105.74 | +47.8% |
| 2020 | 71.55 | +328.3% |
| 2019 | 16.71 | -60.4% |
| 2018 | 42.15 | -68.0% |
| 2017 | 131.80 | +105.8% |
| 2016 | 64.05 | - |